Facial Injectable Market Size Worth USD 29,649 Million By 2025 | COVID-19 Impact, Applications and Global Industry Trends

Facial Injectable Market Size Worth USD 29,649 Million By 2025 | COVID-19 Impact, Applications and Global Industry Trends

“Facial Injectable Market”
Facial Injectables Market Share, Growth and Trends Analysis by Type (Botulinum Toxin, Hyaluronic Acid, Polymers and Particles and Collagen), Application (Facial Line Correction Treatment, Face Lift and Lip Treatments), End User (Hospitals, Specialty Clinics and Spa & Beauty Clinic) and Region (North America, Europe, Asia-Pacific and Middle East & Africa) – Forecast till 2025

According to Market Research Future (MRFR), the global facial injectable market valuation is estimated to reach USD 29,649.7 MN by 2025, registering a whopping CAGR of 28.1% throughout the review period (2019-2025). With extensive research in the field, injectable facial procedures have become far safer and effective.

The Global Facial Injectable Market is witnessing significant growth over recent years as these injectables have become a major game-changer in the beauty industry. Factors such as easy accessibility, relative ease, short recovery time, and almost immediate results have its adoption. Getting facial fillers seems to be an easy option compared to plastic or cosmetic surgery. Moreover, the rising trend of online purchasing of injectable products has encouraged many to adopt facial injectable instead of undergoing a knife. 

Besides, the disappearance of stigma around this sort of procedures due to celebrity endorsement is making facial injectables to become increasingly popular and accessible all over the world. The increasing number of luxury clinics and private cosmetic treatment centers are making this cosmetic trend more visible in the market. Also, the growing availability of world-class aesthetic experts and comprehensive treatment plans tailored to each customer are increasing the size of the facial injectable market.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1527

Resultantly, the facial injectable market has become a well-established and ever-increasing space globally. Manufacturers of these injectables strive to develop new and innovative products that can provide advanced solutions for the users and ease the processes further. As a result, these manufacturers invest substantially to drive required R&D activities, which push the market growth. Additionally, the growing demand for minimally invasive surgeries and visible effects of treatment are spurring the facial injectables market growth.

Also, greater awareness & acceptance of aesthetic medicine, improved accessibility to practitioners in the field, growing aging population, and the rising per capita disposable income are the major factors driving the growth of the market. On the other hand, the recent COVID-19 pandemic is hitting the injectable facial industry hard. COVID-19 prompts fears for users’ mental health; hence, many cosmetic injectable clinics would remain close for some time on.

However, post the pandemic diminishes, the industry is expected to shoot up faster than ever. Another threat that the industry confronts is the big business of fake facial fillers. Though the facial injectable sector is strictly regulated, it, unfortunately, sees a rise in both counterfeit and illegally imported product sales, especially from unlicensed online distributors. Online sales of hyaluronic acid fillers are increasing dramatically, as it is a quick, easy, and relatively inexpensive option of purchasing.

People are buying these fillers without investigating further the authenticity of the product. Although some online sellers maintain strict counterfeit policies, many fake fillers are still floating in the e-commerce market. Also, the DIY procedure trend is picking up speedily, which is an incredibly dangerous and potentially catastrophic trend. Counterfeit fillers and DIY procedures not only trigger side effects but also increase the cost of the procedure by requiring surgical corrections.

Similarly, genuine and certified facial filler too can cause various side effects. Such adverse effects are restricting the growth of the market to a great extent. Simultaneously, the high cost of the injecting procedure, alongside stringent regulations regarding the procedure is further limiting the market growth. Nevertheless, the increasing purchasing power of consumers is projected to support market growth throughout the assessment period.

Facial Injectables Market Segmentation

By Type, the global facial injectables market is segmented into Hyaluronic Acid, Botulinum Toxin, Polymers & Particles, Collagen, and others.

By Application, the global facial injectables market is segmented into Facial Line Correction Treatment, Face Lift and Lip Treatments, and others.

By End User, the global facial injectables market is segmented into Hospitals, Specialty Clinics, Spa & Beauty Clinic, and others.

Facial Injectable Market Regional Analysis

North America dominates the global facial injectable market. The largest share of the market attributes to the increase in the spending on cosmetic procedures and the increasing numbers of treatment facilities. Also, the presence of many players and their range of injectables available in the region drive the market growth. Moreover, factors such as the increasing desire to look picture perfect and rising popularity of facial injectables in the region boost market growth.

Furthermore, the growing trend of DIY injectables and increasing adoption of facial injectables to maintain the youthful looks drive the regional market growth. Moreover, the high per capita disposable income, high expenditures on wellness influence market growth. The North American facial injectable market is predicted to retain its leading position throughout the assessment period.

Europe holds the second-largest share in the facial injectables market.  The market is majorly driven by the huge popularity for facial aesthetics, recent technological advancements, and the increasing uptake of advanced facial injectable in the demographics. Besides, factors such as rising geriatric population, growing consciousness for futuristic beauty treatments, and increasing prominence for physical appearance in the region foster market growth. Continuing with these trends, the European facial injectable market is expected to create a substantial revenue pocket during 2019- 2025.

The Asia Pacific region is coming up as a rapidly growing market for facial injectables globally. Factors such as the development of related technologies, mainly in countries like China, India, and Japan, and the improving economy in the region drive the market growth. Moreover, the growing beauty concerns among the mid-age and elderly population act as major tailwinds for the regional market growth. Backed by the increasing adoption of advanced technologies, the APAC facial injectable market is likely to register a phenomenal CAGR during the review period.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/facial-injectable-market-1527

Facial Injectables Market Competitive Landscape

Fiercely competitive, the global facial injectables market appears fragmented due to the presence of many well-established players. To gain a larger competitive share, innovation, new technology launch, and brand reinforcement remain the popular trends of these players. The growth statistics of the cosmetology industry presage the probable heights the market can reach further. Further, market players are focusing on product launches and expanding their global footprints by entering untapped markets. 

Major Players

Players leading the global facial injectables market are Allergan, Galderma, Merz Pharma, Integra Lifesciences, Valeant Pharmaceuticals, Sanofi, Suneva Medical, Sinclair, and Scivision Biotech Inc., among others.

Facial Injectables Industry/Innovations/Related News:

Revance Therapeutics (the US), a biotechnology company specializing in neuromodulator innovations, introduced TEOXANE RHA® fillers in the US The Company has signed a distribution agreement with a Swiss company TEOXANE SA to sell Teoxane’s hyaluronic acid (HA)-based dermal filler in the US. The partnership gives Revance immediate & exclusive access to the company’s range of Resilient HA (RHA) fillers in the US, with TEOXANE gaining 2.5 million shares of Revance common stock in return.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/facial-injectable-market-1527